PRESS RELEASE published on 08/16/2023 at 07:00, 2 years 11 months ago Biophytis announces next regulatory steps in Europe and the United States for its COVA project
PRESS RELEASE published on 08/08/2023 at 07:00, 2 years 11 months ago Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe
PRESS RELEASE published on 07/20/2023 at 07:00, 3 years ago Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 07/19/2023 at 07:53, 3 years ago Biophytis Announces $3.8 Million Registered Direct Offering
PRESS RELEASE published on 07/18/2023 at 07:00, 3 years ago Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
PRESS RELEASE published on 07/10/2023 at 07:00, 3 years ago Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 06/19/2023 at 07:00, 3 years 1 month ago Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
PRESS RELEASE published on 06/16/2023 at 23:00, 3 years 1 month ago Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED
PRESS RELEASE published on 06/05/2023 at 08:00, 3 years 2 months ago Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June
PRESS RELEASE published on 05/26/2023 at 08:00, 3 years 2 months ago Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1
Published on 08/07/2026 at 00:45, 40 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 2 hours 10 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 3 hours 10 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 3 hours 20 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 3 hours 25 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 22:15, 3 hours 10 minutes ago BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 3 hours 40 minutes ago FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 6 hours 20 minutes ago Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 7 hours 1 minute ago EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026
Published on 08/06/2026 at 18:26, 6 hours 59 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 17:45, 7 hours 40 minutes ago Declaration of voting rights at the end of July 2026
Published on 08/06/2026 at 17:35, 7 hours 50 minutes ago Groupe des Assurances du Crédit Mutuel (GACM)’s Solvency II ratio was 227% as of June 30, 2026
Published on 08/06/2026 at 17:35, 7 hours 50 minutes ago Availability of the financial statements of Groupe des Assurances du Crédit Mutuel for the first half of 2026
